Peer-reviewed report on Moderna COVID-19 vaccine publishes
Scienmag
JANUARY 1, 2021
Data from Phase 3 clinical trial confirm vaccine is effective Credit: NIH WHAT: The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine. The vaccine also demonstrated efficacy in preventing severe […].
Let's personalize your content